Sci Transl Med. 2024 Sep 4;16(763):eabq7378. doi: 10.1126/scitranslmed.abq7378. Epub 2024 Sep 4.
ABSTRACT
Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of age-specific adjuvants will inform precision discovery and development of safe and effective vaccines for protecting children from preventable infectious diseases.
PMID:39231242 | DOI:10.1126/scitranslmed.abq7378
